Switch to:
Also traded in: Germany
» Details

Insider Trades

Latest Guru Trades with BIOC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research    NAICS: 621511    SIC: 8731
Compare:NAS:CHEK, OTCBB:INIS, OTCPK:SYGWF, OTCPK:TDSGF, OTCPK:EDTXF, OTCPK:SEOVF, OTCPK:PRFMF, NAS:DRIO, NAS:TEAR, NAS:WGBS, NAS:ROKA, OTCPK:EXDI, NAS:OPGN, OTCPK:ILIU, NAS:CGIX, OTCPK:MHTX, NAS:CDNA, OTCPK:GNWSF, OTCPK:CRRVF, NAS:TBIO » details
Traded in other countries:B001.Germany,
Biocept Inc is a cancer diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, tests utilizing a standard blood sample or liquid biopsy.

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $2.15
EPS (TTM) $ -2.63
Beta2.66
Short Percentage of Float40.77%
52-Week Range $0.74 - 5.64
Shares Outstanding (Mil)17.50

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 3 6 12
EPS ($) -1.77 -0.89 -0.88
EPS without NRI ($) -1.77 -0.89 -0.88
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for BIOC

Headlines

Articles On GuruFocus.com
Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 

More From Other Websites
Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and Host Investor Conference... Feb 21 2017
Biocept Appoints Michael Terry Senior Vice President Commercial Operations Feb 15 2017
BIOCEPT INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 09 2017
Biocept's CEO Issues Letter to Stockholders Feb 09 2017
GSK warns profits to be hit by generic drugs competition Feb 08 2017
GSK warns profits to be hit by generic drugs competition Feb 08 2017
Biocept to Present at the 19th Annual BIO CEO and Investor Conference Feb 06 2017
BIOCEPT INC Files SEC form 8-K, Other Events Jan 25 2017
ETFs with exposure to Biocept, Inc. : January 19, 2017 Jan 19 2017
Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture... Jan 19 2017
Latest Reports on Biocept and Apricus Biosciences as President Trump's Comments Put Pressure on Drug... Jan 13 2017
Tuesday’s Top Biopharma Movers Jan 10 2017
Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas Jan 10 2017
Columbia University Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform to... Dec 27 2016
Columbia University Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform to... Dec 27 2016
Clinical Utility of Biocept's Liquid Biopsy Platform Demonstrated in Study Results Presented at the... Dec 08 2016
Biocept Presents Robust Analytical Validation Study Results for its PD-L1 Liquid Biopsy Test at the... Dec 07 2016
Teladoc November Visits Set Record: Why is Stock Suffering? Dec 07 2016
ETFs with exposure to Biocept, Inc. : December 5, 2016 Dec 05 2016
BIOCEPT INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule... Dec 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK